TY - JOUR
T1 - Predictors of SUDEP counseling and implications for designing interventions
AU - Barbour, Kristen
AU - Yozawitz, Elissa G.
AU - McGoldrick, Patricia E.
AU - Wolf, Steven
AU - Nelson, Aaron
AU - Grinspan, Zachary M.
N1 - Funding Information:
This work is supported through generous funding from (1) the Centers for Disease Control and Prevention ( U01DP006089 ) and (2) the Epilepsy Research Fund (Epilepsy Research Risk Detection and Prevention of Death Fund). Thank you to Dale Hesdorffer for guidance and support with this project.
Funding Information:
Patricia McGoldrick has served as a speaker for Eisai, Greenwich and Sunovion and on advisory boards to UCB, Neuropace and Supernus. Steven Wolf has served as speaker or consultant for Greenwich Pharma, Eisai Pharma, Neuropace, Lundbeck, UCB, Biomarin, Aquestive, and Zogenix, Neurilis. Zachary Grinspan receives funding for his research from Weill Cornell Medicine, the Pediatric Epilepsy Research Foundation, Clara Inspired, and the Orphan Disease Center. He has performed consulting work for Alpha Insights and Bio-Pharm Solutions (South Korea). The remaining authors have no conflicts of interest.
Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2021/4
Y1 - 2021/4
N2 - Objective: We aimed to describe how often and why clinicians counsel people with epilepsy about sudden unexpected death in epilepsy (SUDEP). Understanding counseling gaps can help design interventions. Methods: We searched clinical notes of 77,924 patients from 2010 to 2014 from six hospitals to find examples of SUDEP counseling and seizure safety counseling. Visits were coded for patient, clinician, and visit factors, and documented reasons for counseling. We evaluated factors associated with SUDEP vs. seizure safety counseling, and reasons for counseling using bivariate and multivariable statistics. Reasons for counseling included: poor medication adherence, lifestyle factors (e.g., poor sleep, drinking alcohol), patient/family reluctance to make recommended medication adjustment, epilepsy surgery considerations, and patient education only. Results: Analysis was restricted to two of six hospitals where 91% of counseling occurred. Documentation of SUDEP counseling was rare (332 of 33,821 patients, 1.0%), almost exclusively by epileptologists (98.5% of counseling), and stable over time, X2 (4, n = 996) = 3.81, p = 0.43. Adult neurologists were more likely to document SUDEP counseling than pediatric (OR = 1.65, 95% CI = 1.12–2.44). Most SUDEP counseling was documented with a goal of seizure reduction (214 of 332, 64.5%), though some was for patient education only (118 of 332, 35.5%). By the time SUDEP counseling was documented, the majority of patients had refractory epilepsy (187 of 332, 56.3%) and/or a potentially modifiable risk factor (214 of 332, 64.5%). Neurologists with more years of clinical experience (OR = 2.18, 95% CI = 1.12–4.25) and more senior academic titles (OR = 2.25, 95% CI = 1.27–3.99) were more likely to document SUDEP counseling for patient education only. People with ≥2 anti-seizure medications (ASM) were more likely to receive counseling for patient education (OR = 2.72, 95% CI = 1.49–4.97). Conclusions: Documentation of SUDEP is rare, and varies by clinician, hospital, and patient factors.
AB - Objective: We aimed to describe how often and why clinicians counsel people with epilepsy about sudden unexpected death in epilepsy (SUDEP). Understanding counseling gaps can help design interventions. Methods: We searched clinical notes of 77,924 patients from 2010 to 2014 from six hospitals to find examples of SUDEP counseling and seizure safety counseling. Visits were coded for patient, clinician, and visit factors, and documented reasons for counseling. We evaluated factors associated with SUDEP vs. seizure safety counseling, and reasons for counseling using bivariate and multivariable statistics. Reasons for counseling included: poor medication adherence, lifestyle factors (e.g., poor sleep, drinking alcohol), patient/family reluctance to make recommended medication adjustment, epilepsy surgery considerations, and patient education only. Results: Analysis was restricted to two of six hospitals where 91% of counseling occurred. Documentation of SUDEP counseling was rare (332 of 33,821 patients, 1.0%), almost exclusively by epileptologists (98.5% of counseling), and stable over time, X2 (4, n = 996) = 3.81, p = 0.43. Adult neurologists were more likely to document SUDEP counseling than pediatric (OR = 1.65, 95% CI = 1.12–2.44). Most SUDEP counseling was documented with a goal of seizure reduction (214 of 332, 64.5%), though some was for patient education only (118 of 332, 35.5%). By the time SUDEP counseling was documented, the majority of patients had refractory epilepsy (187 of 332, 56.3%) and/or a potentially modifiable risk factor (214 of 332, 64.5%). Neurologists with more years of clinical experience (OR = 2.18, 95% CI = 1.12–4.25) and more senior academic titles (OR = 2.25, 95% CI = 1.27–3.99) were more likely to document SUDEP counseling for patient education only. People with ≥2 anti-seizure medications (ASM) were more likely to receive counseling for patient education (OR = 2.72, 95% CI = 1.49–4.97). Conclusions: Documentation of SUDEP is rare, and varies by clinician, hospital, and patient factors.
KW - Counseling
KW - Disclosure
KW - Electronic health records
KW - Epilepsy
KW - Intervention
KW - Sudden unexpected death in epilepsy
UR - http://www.scopus.com/inward/record.url?scp=85101112157&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85101112157&partnerID=8YFLogxK
U2 - 10.1016/j.yebeh.2021.107828
DO - 10.1016/j.yebeh.2021.107828
M3 - Article
C2 - 33636525
AN - SCOPUS:85101112157
SN - 1525-5050
VL - 117
JO - Epilepsy and Behavior
JF - Epilepsy and Behavior
M1 - 107828
ER -